Latest Ceo Appointments News

Yugo Metals has appointed Petar Tomašević as its permanent CEO, following his interim leadership that saw significant project milestones. His international experience and regional insight position the company for accelerated growth in Europe's strategic metals sector.

Lithium Universe Limited appoints Iggy Tan as full-time CEO and Executive Chairman, signalling a strategic push to fast-track lithium refinery projects and innovative recycling technologies.

Buru Energy’s CEO Thomas Nador resigns due to health reasons, with interim leadership stepping in as the company advances its Rafael Gas Project.

Coronado Global Resources has announced the resignation of CEO Douglas Thompson, appointing former CEO and current Executive Chair Gerry Spindler as interim leader. The board also welcomes Greg Pritchard as the new Chair.

Woodside Energy has appointed Elizabeth Westcott as its new CEO and Managing Director, confirming leadership continuity amid key growth projects. Westcott’s extensive industry experience and performance-linked incentives underscore Woodside’s focus on sustainable value creation.

Power Minerals has appointed Alistair Stephens, a seasoned rare earths executive, as CEO to spearhead development of its South American critical minerals projects. Stephens brings decades of leadership experience and a proven track record in scaling rare earth ventures.

InteliCare Holdings has appointed seasoned healthcare executive Angus Cameron as CEO to lead its transition from pilot projects to full-scale commercial deployment following a major aged care contract.

Verbrec Limited has promoted Mark Read from CEO to Managing Director, extending his notice period to ensure leadership continuity as the company builds on its recent turnaround.

Kalamazoo Resources has appointed mining veteran Andrew McDougall as CEO to lead its flagship Ashburton Gold Project through critical feasibility stages and drive broader portfolio growth.

Murray Cod Australia Ltd reported a 40% revenue increase to $6.69 million for H1 2026 but swung to a $4.06 million net loss, reflecting significant investments and operational expansion.

DorsaVi Limited reported a steep increase in its half-year loss to $3.6 million, driven by declining revenues and a sharp rise in operating costs, despite raising over $5 million in fresh capital.

Patrys Limited reported a near doubling of its half-year loss to $3.02 million, driven by restructuring and a strategic pivot including the acquisition of Reliis Pty Ltd. The company is advancing a dual-platform biotech strategy combining a clinical-stage CNS asset with its proprietary antibody platform.